Swiss National Bank’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.68M | Sell |
681,646
-23,500
| -3% | -$265K | ﹤0.01% | 1061 |
|
|
2025
Q1 | $7.11M | Sell |
705,146
-22,100
| -3% | -$223K | 0.01% | 1063 |
|
|
2024
Q4 | $8.6M | Buy |
727,246
+6,200
| +0.9% | +$73.3K | 0.01% | 1021 |
|
|
2024
Q3 | $8.32M | Buy |
721,046
+6,900
| +1% | +$79.6K | 0.01% | 1036 |
|
|
2024
Q2 | $7.55M | Buy |
714,146
+158,600
| +29% | +$1.68M | 0.01% | 1026 |
|
|
2024
Q1 | $5.86M | Buy |
555,546
+8,800
| +2% | +$92.8K | ﹤0.01% | 1191 |
|
|
2023
Q4 | $6.14M | Buy |
546,746
+41,000
| +8% | +$460K | ﹤0.01% | 1160 |
|
|
2023
Q3 | $5.91M | Sell |
505,746
-237,300
| -32% | -$2.77M | ﹤0.01% | 1180 |
|
|
2023
Q2 | $7.49M | Buy |
743,046
+116,800
| +19% | +$1.18M | 0.01% | 1063 |
|
|
2023
Q1 | $4.62M | Sell |
626,246
-54,100
| -8% | -$399K | ﹤0.01% | 1326 |
|
|
2022
Q4 | $5.44M | Buy |
680,346
+28,300
| +4% | +$226K | ﹤0.01% | 1270 |
|
|
2022
Q3 | $2.1M | Hold |
652,046
| – | – | ﹤0.01% | 1849 |
|
|
2022
Q2 | $2.65M | Buy |
+652,046
| New | +$2.65M | ﹤0.01% | 1718 |
|